These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Application of Proteomic Techniques for Improved Stratification and Treatment of Schizophrenia Patients. Steiner J; Guest PC; Martins-de-Souza D Adv Exp Med Biol; 2017; 974():3-19. PubMed ID: 28353222 [TBL] [Abstract][Full Text] [Related]
7. A Clinical Study Protocol to Identify Serum Biomarkers Predictive of Response to Antipsychotics in Schizophrenia Patients. Steiner J; Guest PC Adv Exp Med Biol; 2017; 974():245-250. PubMed ID: 28353242 [TBL] [Abstract][Full Text] [Related]
8. Revisiting biomarker discovery by plasma proteomics. Geyer PE; Holdt LM; Teupser D; Mann M Mol Syst Biol; 2017 Sep; 13(9):942. PubMed ID: 28951502 [TBL] [Abstract][Full Text] [Related]
9. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics. Lee HJ; Lee EY; Kwon MS; Paik YK Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010 [TBL] [Abstract][Full Text] [Related]
11. Catch and measure-mass spectrometry-based immunoassays in biomarker research. Weiß F; van den Berg BH; Planatscher H; Pynn CJ; Joos TO; Poetz O Biochim Biophys Acta; 2014 May; 1844(5):927-32. PubMed ID: 24060810 [TBL] [Abstract][Full Text] [Related]
12. Hippocampal Proteomic and Metabonomic Abnormalities in Neurotransmission, Oxidative Stress, and Apoptotic Pathways in a Chronic Phencyclidine Rat Model. Wesseling H; Want EJ; Guest PC; Rahmoune H; Holmes E; Bahn S J Proteome Res; 2015 Aug; 14(8):3174-87. PubMed ID: 26043028 [TBL] [Abstract][Full Text] [Related]
13. Qualification and Verification of Protein Biomarker Candidates. Zhao Y; Brasier AR Adv Exp Med Biol; 2016; 919():493-514. PubMed ID: 27975232 [TBL] [Abstract][Full Text] [Related]
14. Plasma/Serum Proteomics based on Mass Spectrometry. Zhu Y Protein Pept Lett; 2024; 31(3):192-208. PubMed ID: 38869039 [TBL] [Abstract][Full Text] [Related]
15. Search for cerebrospinal fluid biomarkers in patients with major psychiatric disorders: Multiplex immunoassay findings and proximity extension assay prospects. Hidese S Neuropsychopharmacol Rep; 2024 Jun; 44(2):314-320. PubMed ID: 38686540 [TBL] [Abstract][Full Text] [Related]
17. The Application of Multiplex Biomarker Techniques for Improved Stratification and Treatment of Schizophrenia Patients. Steiner J; Guest PC; Rahmoune H; Martins-de-Souza D Methods Mol Biol; 2017; 1546():19-35. PubMed ID: 27896755 [TBL] [Abstract][Full Text] [Related]
18. Application of Proteomic Approaches to Accelerate Drug Development for Psychiatric Disorders. Rahmoune H; Martins-de-Souza D; Guest PC Adv Exp Med Biol; 2017; 974():69-84. PubMed ID: 28353225 [TBL] [Abstract][Full Text] [Related]
19. Accuracy and Reproducibility in Quantification of Plasma Protein Concentrations by Mass Spectrometry without the Use of Isotopic Standards. Kramer G; Woolerton Y; van Straalen JP; Vissers JP; Dekker N; Langridge JI; Beynon RJ; Speijer D; Sturk A; Aerts JM PLoS One; 2015; 10(10):e0140097. PubMed ID: 26474480 [TBL] [Abstract][Full Text] [Related]
20. Identification of a molecular profile associated with immune status in first-onset schizophrenia patients. Herberth M; Rahmoune H; Schwarz E; Koethe D; Harris LW; Kranaster L; Witt SH; Spain M; Barnes A; Schmolz M; Leweke MF; Guest PC; Bahn S Clin Schizophr Relat Psychoses; 2014 Jan; 7(4):207-15. PubMed ID: 23395839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]